Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 31

Publication Record

Connections

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
McDermott DF, Huseni MA, Atkins MB, Motzer RJ, Rini BI, Escudier B, Fong L, Joseph RW, Pal SK, Reeves JA, Sznol M, Hainsworth J, Rathmell WK, Stadler WM, Hutson T, Gore ME, Ravaud A, Bracarda S, Suárez C, Danielli R, Gruenwald V, Choueiri TK, Nickles D, Jhunjhunwala S, Piault-Louis E, Thobhani A, Qiu J, Chen DS, Hegde PS, Schiff C, Fine GD, Powles T
(2018) Nat Med 24: 749-757
MeSH Terms: Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Carcinoma, Renal Cell, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Kaplan-Meier Estimate, Kidney Neoplasms, Male, Middle Aged, Mutation, Sunitinib, Treatment Outcome
Added October 30, 2019
0 Communities
1 Members
0 Resources
19 MeSH Terms
A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma.
Mudigonda TV, Wyman K, Spigel DR, Dahlman KB, Greco FA, Puzanov I, Kelley MC, Hainsworth JD, Sosman JA, Johnson DB
(2016) Pigment Cell Melanoma Res 29: 101-3
MeSH Terms: Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Disease-Free Survival, Erlotinib Hydrochloride, Humans, Melanoma, Neoplasm Metastasis, Treatment Outcome
Added February 16, 2016
0 Communities
1 Members
0 Resources
8 MeSH Terms
A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) study.
Dandamudi UB, Ghebremichael M, Sosman JA, Clark JI, McDermott DF, Atkins MB, Dutcher JP, Urba WJ, Regan MM, Puzanov I, Crocenzi TS, Curti BD, Vaishampayan UN, Crosby NA, Margolin KA, Ernstoff MS
(2013) J Immunother 36: 490-5
MeSH Terms: Adult, Aged, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Carcinoma, Renal Cell, Dose-Response Relationship, Drug, Drug Administration Schedule, Fatigue, Female, Follow-Up Studies, Humans, Hypotension, Infusions, Intravenous, Interleukin-2, Kaplan-Meier Estimate, Karnofsky Performance Status, Kidney Neoplasms, Lymphopenia, Male, Middle Aged, Neoplasm Metastasis, Treatment Outcome
Added March 7, 2014
0 Communities
2 Members
0 Resources
23 MeSH Terms
A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer.
Berlin J, Bendell JC, Hart LL, Firdaus I, Gore I, Hermann RC, Mulcahy MF, Zalupski MM, Mackey HM, Yauch RL, Graham RA, Bray GL, Low JA
(2013) Clin Cancer Res 19: 258-67
MeSH Terms: Adult, Aged, Aged, 80 and over, Anilides, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Camptothecin, Colorectal Neoplasms, Female, Fluorouracil, Humans, Leucovorin, Male, Maximum Tolerated Dose, Middle Aged, Neoplasm Metastasis, Organoplatinum Compounds, Proto-Oncogene Proteins, Proto-Oncogene Proteins p21(ras), Pyridines, Treatment Outcome, ras Proteins
Added March 7, 2014
0 Communities
1 Members
0 Resources
23 MeSH Terms
Is renal thrombotic angiopathy an emerging problem in the treatment of ovarian cancer recurrences?
Kwa M, Baumgartner R, Shavit L, Barash I, Michael J, Puzanov I, Kopolovic J, Rosengarten O, Blank S, Curtin JP, Gabizon A, Muggia F
(2012) Oncologist 17: 1534-40
MeSH Terms: Adult, Aged, Antibodies, Monoclonal, Humanized, Bevacizumab, Creatinine, Deoxycytidine, Doxorubicin, Fatal Outcome, Female, Humans, Middle Aged, Ovarian Neoplasms, Platinum, Polyethylene Glycols, Quality of Life, Recurrence, Renal Insufficiency, Chronic, Retrospective Studies, Risk Factors, Taxoids, Thrombosis, Topotecan
Added March 5, 2014
0 Communities
1 Members
0 Resources
22 MeSH Terms
Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume.
Pechman KR, Donohoe DL, Bedekar DP, Kurpad SN, Schmainda KM
(2012) Magn Reson Med 68: 1266-72
MeSH Terms: Animals, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Blood Volume, Blood Volume Determination, Brain Neoplasms, Camptothecin, Cell Line, Tumor, Cerebrovascular Circulation, Irinotecan, Magnetic Resonance Imaging, Male, Rats, Rats, Nude, Reproducibility of Results, Sensitivity and Specificity, Treatment Outcome
Added March 6, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma.
Kim KB, Sosman JA, Fruehauf JP, Linette GP, Markovic SN, McDermott DF, Weber JS, Nguyen H, Cheverton P, Chen D, Peterson AC, Carson WE, O'Day SJ
(2012) J Clin Oncol 30: 34-41
MeSH Terms: Adult, Aged, Aged, 80 and over, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Carboplatin, Double-Blind Method, Drug Administration Schedule, Female, Humans, Infusions, Intravenous, Kaplan-Meier Estimate, Male, Melanoma, Middle Aged, Paclitaxel, Skin Neoplasms, Treatment Outcome
Added March 20, 2014
0 Communities
1 Members
0 Resources
20 MeSH Terms
Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on hypertension.
Nazer B, Humphreys BD, Moslehi J
(2011) Circulation 124: 1687-91
MeSH Terms: Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Bevacizumab, Cardiovascular Diseases, Follow-Up Studies, Humans, Hypertension, Male, Medical Oncology, Middle Aged, Neoplasms, Prostatectomy, Prostatic Neoplasms
Added March 4, 2015
0 Communities
1 Members
0 Resources
13 MeSH Terms
Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE).
Polite BN, Sing A, Sargent DJ, Grothey A, Berlin J, Kozloff M, Feng S
(2012) Cancer 118: 1083-90
MeSH Terms: African Continental Ancestry Group, Aged, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Cohort Studies, Colorectal Neoplasms, Drug Therapy, Combination, European Continental Ancestry Group, Female, Follow-Up Studies, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Metastasis, Outcome Assessment, Health Care, Prospective Studies, Survival Rate, Treatment Outcome, United States
Added March 20, 2014
0 Communities
1 Members
0 Resources
23 MeSH Terms
Characterization of bevacizumab dose response relationship in U87 brain tumors using magnetic resonance imaging measures of enhancing tumor volume and relative cerebral blood volume.
Pechman KR, Donohoe DL, Bedekar DP, Kurpad SN, Hoffmann RG, Schmainda KM
(2011) J Neurooncol 105: 233-9
MeSH Terms: Angiogenesis Inhibitors, Animals, Antibodies, Monoclonal, Humanized, Bevacizumab, Blood Volume, Brain Neoplasms, Contrast Media, Dose-Response Relationship, Drug, Gadolinium DTPA, Glioblastoma, Humans, Magnetic Resonance Imaging, Male, Rats, Tumor Burden, Tumor Cells, Cultured
Added March 6, 2020
0 Communities
1 Members
0 Resources
MeSH Terms